CardioNerds at SCAI SCHOCK 2022
Welcome to the CardioNerds at SCAI SHOCK 2022 Knowledge Hub, powered by CardioNerds. View in-depth video interviews with key opinion leaders in the cardiology space, featuring the latest data on enhancing multidisciplinary care in cardiogenic shock and highlights from the 2022 conference, which took place October 13-15 in Minneapolis, Minnesota.
Advertisement
In the FlowTriever for Acute Massive Pulmonary Embolism (FLAME) study, researchers aimed to assess treatment outcomes of ...
Cardiogenic shock is challenging to treat, and traditionally results in poor outcomes. Therefore, it is critical to ...
The Incorporating SuperSaturated Oxygen in Shock (ISO-Shock) study assessed the safety and efficacy of TherOx ...
The Cardiogenic Shock Working Group (CSWG) is a multicenter registry developed to collate clinical data on shock ...
Cardiogenic shock treatment in the United States has changed as novel therapies and innovative devices have emerged in ...
The National Cardiogenic Shock Initiative (NCSI) aims to bring together centers from across the U.S. that specialize in ...
The RECOVER IV trial is a two-arm study that seeks to analyze whether percutaneous coronary intervention (PCI) with ...
The CAPITAL DOREMI 2 study is a multi-centre, double-blind, randomized controlled trial which assessed the safety and ...
The recent DanGer Shock trial sought to assess if the use of left ventricular mechanical circulatory support using ...
The Pulmonary Artery Catheter in Cardiogenic Shock Trial (PACCS) was conducted to analyze if early invasive hemodynamic ...
Despite advances in treatment, cardiogenic shock (CS) outcomes remain dire. As such, researchers initiated the ...
The American Heart Association (AHA) recently created the Cardiogenic Shock Registry to enhance the quality of care and ...
Advertisement
